Renal Protection GLP-1 agonists have been observed to exert beneficial actions on the kidneys, including improved filtration, reduced inflammation, and enhanced protection against diabetic kidney damage
It's also used for respiratory conditions, liver support, and to potentially enhance cognitive function and exercise performance
Obesity is a long-term medical condition shaped by genetics, environment, and behavior
When used as monotherapy or in combination with metformin, the risk of clinically significant hypoglycemia is relatively low, typically less than five percent, due to the glucose-dependent nature of semaglutides insulin secretion
Constipation prevention through diet Constipation affects roughly 10-15% of GLP-1 users and can become severe enough to require medical attention
Less necrosis developed in treated wounds, suggesting the peptide helped preserve marginally viable tissue that might otherwise have died